Aristotle Atlantic Partners, LLC released its second quarter 2025 investor letter, noting a 10.94% rise in the S&P 500 Index. Their Large Cap Growth Strategy delivered 18.45% net of fees, outperforming the Russell 1000 Growth Index’s 17.84% return. Check their top five holdings for their best picks in 2025.

Bio-Techne Corporation (NASDAQ: TECH) was highlighted in Aristotle Atlantic’s letter. With a market cap of $8.58 billion, the company develops life science reagents. Despite a one-month return of 2.99%, shares lost 31.73% in the last 52 weeks, closing at $54.73 on July 31, 2025.

Bio-Techne Corporation faced challenges in Q2 due to concerns in the life sciences industry. Despite this, they issued a positive earnings report and are poised for recovery. Aristotle Atlantic believes Bio-Techne will rebound once funding issues are resolved.

Bio-Techne Corporation is not among the 30 most popular stocks among hedge funds. 34 hedge funds held Bio-Techne by the end of Q1, up from 24 in the previous quarter. In Q3 2025, the company generated $316.2 million in revenues, showcasing growth potential. Consider other AI stocks for greater upside potential.

Read more at Yahoo Finance: Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns